The newly formed consortium brings together EU-leading expertise in data science, biotechnology, clinical research as well as public involvement. As the project title already highlights, the partners aim to advance research into one of the most challenging conditions, Alzheimer’s disease.
Given the rising number of people affected and challenges around diagnosis (which often comes late in the disease course), new markers for the condition could be valuable to diagnose people earlier. In addition to this, project results could support more precise treatment research (patient stratification).
Company Details
- Founded
- 2022
- Address
- Sankt Augustin, De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.adis-project.eu
- HQ
- Sankt Augustin
- Competitors
- UCD Charles Institute of Dermatology, European Platform for Neurodegenerative Diseases (EPND), CogniScent, JPND - EU Joint-Programme Neurodegenerative Disease Research, Medtech Magazine, EMDR Centre London, The Alzheimer's & Dementia Show, IHI-PROMINENT, The AI-Mind Project, LETHE Project.
Adis Jpnd Questions
Adis Jpnd's website is http://www.adis-project.eu
Adis Jpnd's LinkedIn profile is https://de.linkedin.com/company/adis-jpnd
Adis Jpnd's industry is
Biotechnology Research
Adis Jpnd's top competitors are
Ucd Charles Institute Of Dermatology,
European Platform For Neurodegenerative Diseases (Epnd),
Cogniscent,
Jpnd - Eu Joint-Programme Neurodegenerative Disease Research,
Medtech Magazine,
Emdr Centre London,
The Alzheimer's & Dementia Show,
Ihi-Prominent,
The Ai-Mind Project,
Lethe Project.
Adis Jpnd's categories are Biotechnology Research
Adis Jpnd's founding year is 2022
